We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$292M
AUM Growth
+$21.1M
Cap. Flow
-$146K
Cap. Flow %
-0.05%
Top 10 Hldgs %
19.9%
Holding
125
New
1
Increased
41
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$1.88M
2
CORT icon
Corcept Therapeutics
CORT
+$497K
3
BOX icon
Box
BOX
+$406K
4
EDIT icon
Editas Medicine
EDIT
+$328K
5
LOXO
Loxo Oncology, Inc
LOXO
+$308K

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$1.69M
2
NTRA icon
Natera
NTRA
+$1.15M
3
EPAM icon
EPAM Systems
EPAM
+$996K
4
RNG icon
RingCentral
RNG
+$820K
5
PAYC icon
Paycom
PAYC
+$799K

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 22.23%
3 Communication Services 12.4%
4 Consumer Discretionary 10.65%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPAM icon
76
EPAM Systems
EPAM
$5.51B
$1.87M 0.64%
13,631
-7,396
-35% -$996K
EDIT icon
77
Editas Medicine
EDIT
$396M
$1.86M 0.64%
57,406
+10,138
+21% +$328K
FRC
78
DELISTED
First Republic Bank
FRC
$1.86M 0.64%
19,345
– –
SNPS icon
79
Synopsys
SNPS
$74.4B
$1.85M 0.64%
18,804
– –
AMRC icon
80
Ameresco
AMRC
$1.12B
$1.85M 0.63%
138,014
– –
NTRA icon
81
Natera
NTRA
$38.3B
$1.81M 0.62%
81,783
-47,558
-37% -$1.15M
GEO icon
82
The GEO Group
GEO
$4.13B
$1.81M 0.62%
73,774
+4,267
+6% +$109K
AKAM icon
83
Akamai
AKAM
$16.7B
$1.8M 0.62%
24,892
– –
PBYI icon
84
Puma Biotechnology
PBYI
$404M
$1.8M 0.62%
39,209
+2,912
+8% +$140K
MPT
85
Medical Properties Trust
MPT
$2.77B
$1.79M 0.61%
123,880
– –
PNFP icon
86
Pinnacle Financial Partners Inc
PNFP
$15.9B
$1.78M 0.61%
29,448
+3,019
+11% +$191K
VICR icon
87
Vicor
VICR
$9.56B
$1.77M 0.61%
39,359
– –
PFBC icon
88
Preferred Bank
PFBC
$1.24B
$1.76M 0.61%
29,998
+1,707
+6% +$107K
CASA
89
DELISTED
Casa Systems, Inc. Common Stock
CASA
$1.76M 0.6%
118,432
+19,775
+20% +$301K
UHS icon
90
Universal Health Services
UHS
$10.2B
$1.75M 0.6%
13,890
– –
TSRO
91
DELISTED
TESARO, Inc.
TSRO
$1.75M 0.6%
45,567
+8,043
+21% +$284K
ASMB icon
92
Assembly Biosciences
ASMB
$498M
$1.75M 0.6%
3,916
+526
+16% +$246K
KPTI icon
93
Karyopharm Therapeutics
KPTI
$43.5M
$1.74M 0.6%
+6,800
New +$1.88M
CVLG icon
94
Covenant Logistics
CVLG
$894M
$1.74M 0.6%
119,814
+10,196
+9% +$154K
MCHP icon
95
Microchip Technology
MCHP
$40.3B
$1.73M 0.59%
44,122
– –
ARE icon
96
Alexandria Real Estate Equities
ARE
$8.97B
$1.71M 0.58%
13,892
– –
HAIN icon
97
Hain Celestial
HAIN
$45M
$1.69M 0.58%
63,762
+3,829
+6% +$109K
KURA icon
98
Kura Oncology
KURA
$800M
$1.68M 0.58%
96,352
– –
EGRX
99
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.66M 0.57%
24,084
– –
MPWR icon
100
Monolithic Power Systems
MPWR
$70.1B
$1.63M 0.56%
12,927
-4,433
-26% -$618K
1 2 3
4
5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Capital Impact Advisors held 125 positions worth $292M, up 7.8% from $270M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 1.6%. Capital Impact Advisors opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2018 buy was Karyopharm Therapeutics: 6,800 shares worth $1.74M.
  • Capital Impact Advisors added most to Corcept Therapeutics in Q3 2018, an estimated $497K increase.
  • Capital Impact Advisors's biggest Q3 2018 reduction was Natera, cutting an estimated $1.15M.
  • Capital Impact Advisors fully exited Super Micro Computer in Q3 2018, selling an estimated $1.69M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $292M portfolio in Q3 2018.
  • Capital Impact Advisors opened 1 new position and closed 1 in Q3 2018.
  • Capital Impact Advisors's portfolio value rose 7.8% quarter-over-quarter to $292M.

Based on Capital Impact Advisors's 13F filing for Q3 2018, filed 19 Oct 2018.